Sally Dawson
A A A

Publications

Jump to: 2014 | 2013 | 2012 | 2011 | 2010 | 2007 | 2005 | 2004 | 2003 | 2002 | 2000 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990
Number of items: 60.

2014

Al-Malky, G; Dawson, SJ; Sirimanna, T; Bagkeris, E; Suri, R; (2014) High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis. J Cyst Fibros 10.1016/j.jcf.2014.07.009.

Al-Malky, G; Dawson, SJ; Suri, R; Sirimanna, T; (2014) Normal hearing in a child with the m.1555A>G mutation despite repeated exposure to aminoglycosides. Has the penetrance of this pharmacogenetic interaction been overestimated? International Journal of Pediatric Otorhinolaryngology , 78 (6) 969 - 973. 10.1016/j.ijporl.2014.02.015.

Al-Malky, G; Suri, R; Sirimanna, T; Dawson, SJ; (2014) Normal hearing in a child with the m.1555A>G mutation despite repeated exposure to aminoglycosides. Has the penetrance of this pharmacogenetic interaction been overestimated? INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY , 78 (6) 969 - 973. 10.1016/j.ijpor1.2014.02.015.

Al-Malky, G; Suri, R; Sirimanna, T; Dawson, SJ; (2014) Normal hearing in a child with the m.1555A>G mutation despite repeated exposure to aminoglycosides. Has the penetrance of this pharmacogenetic interaction been overestimated? Int J Pediatr Otorhinolaryngol 10.1016/j.ijporl.2014.02.015.

2013

Linden Phillips, L; Bitner-Glindzicz, M; Lench, N; Steel, KP; Langford, C; Dawson, SJ; ... Packer, C; + view all (2013) The future role of genetic screening to detect newborns at risk of childhood-onset hearing loss. Int J Audiol , 52 (2) 124 - 133. 10.3109/14992027.2012.733424.

Nolan, LS; Cadge, BA; Gomez-Dorado, M; Dawson, SJ; (2013) A functional and genetic analysis of SOD2 promoter variants and their contribution to age-related hearing loss. Mechanisms of Ageing and Development , 134 (7-8) 298 - 306. 10.1016/j.mad.2013.02.009.

Nolan, LS; Cadge, BA; Gomez-Dorado, M; Dawson, SJ; (2013) A functional and genetic analysis of SOD2 promoter variants and their contribution to age-related hearing loss. Mech Ageing Dev , 134 (7-8) 298 - 306. 10.1016/j.mad.2013.02.009.

Nolan, LS; Ecob, R; Cadge, BA; Davis, A; Dawson, SJ; Maier, H; ... Strachan, DP; + view all (2013) Estrogen-related receptor gamma and hearing function: evidence of a role in humans and mice. Neurobiology of Aging , 34 (8) 10.1016/j.neurobiolaging.2013.02.009.

Nolan, LS; Maier, H; Hermans-Borgmeyer, I; Girotto, G; Ecob, R; Pirastu, N; ... Dawson, SJ; + view all (2013) Estrogen-related receptor gamma and hearing function: evidence of a role in humans and mice. Neurobiol Aging , 34 (8) 2077.e1 - 2077.e9. 10.1016/j.neurobiolaging.2013.02.009. Green and gold open access
file

Nolana, LS; Maierb, H; Hermans-Borgmeyerc, I; Girottod, G; Ecoba, R; Pirastud, N; ... Dawson, SJ; + view all (2013) ESRRG and hearing function; evidence of a role in humans and mice. Neurobiology of Aging (In press).

2012

Dawson, SJ; (2012) The genetics of ototoxicity. ENT and Audiology News , 21 (1) 70 - 73.

2011

Al-Malky, G; Suri, R; Dawson, SJ; Sirimanna, T; Kemp, D; (2011) Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: A study using extended high-frequency audiometry and distortion product otoacoustic emissions. INT J AUDIOL , 50 (2) 112 - 122. 10.3109/14992027.2010.524253.

Al-Malky, G; Suri, R; Dawson, SJ; Sirimanna, T; Kemp, D; (2011) Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: A study using extended high-frequency audiometry and distortion product otoacoustic emissions. INT J AUDIOL , 50 (2) 112 - 122. 10.3109/14992027.2010.524253.

Towers, ER; Kelly, JJ; Sud, R; Gale, JE; Dawson, SJ; (2011) Caprin-1 is a target of the deafness gene Pou4f3 and is recruited to stress granules in cochlear hair cells in response to ototoxic damage. J CELL SCI , 124 (7) 1145 - 1155. 10.1242/jcs.076141. Gold open access

2010

DAWSON, S; (2010) The Role of Genetics in Age-Related Hearing Loss. ENT & Audiology News , 19 (4) 100 - 102.

2007

Nolan, LS; Jagutpal, SS; Cadge, BA; Woo, P; Dawson, SJ; (2007) Identification and functional analysis of common sequence variants in the DFNA15 gene, Brn-3c. GENE , 400 (1-2) 89 - 97. 10.1016/j.gene.2007.05.023.

2005

Sud, R; Jones, CM; Banfi, S; Dawson, SJ; (2005) Transcriptional regulation by Barh11 and Brn-3c in organ of corti derived cell lines. MOL BRAIN RES , 141 (2) 174 - 180. 10.1016/j.molbrainres.2005.09.007.

Sud, R; Jones, CM; Dawson, SJ; Banfi, S; (2005) Transcriptional regulation by Barhl1 and Brn-3c in organ of corti derived cell lines. Molecular Brain Research , 141 (2) 174 - 180. 10.1016/j.molbrainres.2005.09.007.

Sud, R.; Jones, C.M.; Banfi, S.; Dawson, S.J.; (2005) Transcriptional regulation by Barhl1 and Brn-3c in organ of corti derived cell lines. Molecular Brain Research , 141 (2) pp. 174-180. 10.1016/j.molbrainres.2005.09.007.

2004

Clough, RL; Sud, R; Davis-Silberman, N; Hertzano, R; Avraham, KB; Holley, M; Dawson, SJ; (2004) Brn-3c (POU4F3) regulates BDNF and NT-3 promoter activity. BIOCHEM BIOPH RES CO , 324 (1) 372 - 381. 10.1016/j.bbrc.2004.09.074.

2003

Weiss, S; Gottfried, I; Mayrose, I; Khare, SL; Xiang, MQ; Dawson, SJ; Avraham, KB; (2003) The DFNA15 deafness mutation affects POU4F3 protein stability, localization, and transcriptional activity. MOL CELL BIOL , 23 (22) 7957 - 7964. 10.1128/MCB.23.22.7957-7964.2003.

2002

Lindahl, GE; Chambers, RC; Papakrivopoulou, J; Dawson, SJ; Jacobsen, MC; Bishop, JE; Laurent, GJ; (2002) Activation of fibroblast procollagen alpha 1(I) transcription by mechanical strain is transforming growth factor-beta-dependent and involves increased binding of CCAAT-binding factor (CBF/NF-Y) at the proximal promoter. J BIOL CHEM , 277 (8) 6153 - 6161. 10.1074/jbc.M108966200. Gold open access

2000

Avraham, KB; Khare, SL; Xiang, M; Dawson, SJ; Weiss, S; (2000) The biological basis for autosomal dominant nonsyndromic hearing loss DFNA15: expression, DNA binding and transcription properties. Presented at: 50th Annual American Society of Human Genetics (ASHG) Meeting, Pennsylvania Convention Center, Philadelphia, PA.

1998

Dawson, SJ; Palmer, RD; Morris, PJ; Latchman, DS; (1998) Functional role of position 22 in the homeodomain of Brn-3 transcription factors. NEUROREPORT , 9 (10) 2305 - 2309.

Gay, RD; Dawson, SJ; Murphy, WJ; Russell, SW; Latchman, DS; (1998) Activation of the iNOS gene promoter by Brn-3 POU family transcription factors is dependent upon the octamer motif in the promoter. BBA-GENE STRUCT EXPR , 1443 (3) 315 - 322.

Liu, YZ; Lee, IK; Locke, I; Dawson, SJ; Latchman, DS; (1998) Adjacent proline residues in the inhibitory domain of the Oct-2 transcription factor play distinct functional roles. NUCLEIC ACIDS RES , 26 (10) 2464 - 2472. Gold open access

Smith, MD; Dawson, SJ; Boxer, LM; Latchman, DS; (1998) The N-terminal domain unique to the long form of the Brn-3a transcription factor is essential to protect neuronal cells from apoptosis and for the activation of Bcl-2 gene expression. NUCLEIC ACIDS RES , 26 (18) 4100 - 4107. Gold open access

1997

Deans, ZC; Dawson, SJ; Kilimann, MW; Wallace, D; Wilson, MC; Latchman, DS; (1997) Differential regulation of genes encoding synaptic proteins by the Oct-2 transcription factor. MOL BRAIN RES , 51 (1-2) 1 - 7.

Gay, RD; Dawson, SJ; Latchman, DS; (1997) The different inhibitory domains of the Oct-2 transcription factor have distinct functional activities. FEBS LETT , 416 (2) 135 - 138.

Morris, PJ; Dawson, SJ; Wilson, MC; Latchman, DS; (1997) A single residue within the homeodomain of the Brn-3 POU family transcription factors determines whether they activate or repress the SNAP-25 promoter. NEUROREPORT , 8 (8) 2041 - 2045.

Smith, MD; Dawson, SJ; Latchman, DS; (1997) Inhibition of neuronal process outgrowth and neuronal specific gene activation by the Brn-3b transcription factor. J BIOL CHEM , 272 (2) 1382 - 1388. Gold open access

Smith, MD; Dawson, SJ; Latchman, DS; (1997) The Brn-3a transcription factor induces neuronal process outgrowth and the coordinate expression of genes encoding synaptic proteins. MOL CELL BIOL , 17 (1) 345 - 354.

Smith, MD; Morris, PJ; Dawson, SJ; Schwartz, ML; Schlaepfer, WW; Latchman, DS; (1997) Coordinate induction of the three neurofilament genes by the Brn-3a transcription factor. J BIOL CHEM , 272 (34) 21325 - 21333. Gold open access

1996

BudhramMahadeo, V; Morris, PJ; Lakin, ND; Dawson, SJ; Latchman, DS; (1996) The different activities of the two activation domains of the Brn-3a transcription factor are dependent on the context of the binding site. J BIOL CHEM , 271 (15) 9108 - 9113. Gold open access

Dawson, SJ; Liu, YZ; Rodel, B; Moroy, T; Latchman, DS; (1996) The ability of POU family transcription factors to activate or repress gene expression is dependent on the spacing and context of their specific response elements. BIOCHEM J , 314 439 - 443.

Dawson, SJ; Morris, PJ; Latchman, DS; (1996) A single amino acid change converts an inhibitory transcription factor into an activator. J BIOL CHEM , 271 (20) 11631 - 11633. Gold open access

Deans, Z; Dawson, SJ; Xie, JL; Young, AP; Wallace, D; Latchman, DS; (1996) Differential regulation of the two neuronal nitric-oxide synthase gene promoters by the Oct-2 transcription factor. J BIOL CHEM , 271 (50) 32153 - 32158. Gold open access

Liu, YZ; Dawson, SJ; Gerster, T; Friedl, E; Pengue, G; Matthias, P; ... Latchman, DS; + view all (1996) The ability of the inhibitory domain of the POU family transcription factor Oct-2 to interfere with promoter activation by different classes of activation domains is dependent upon the nature of the basal promoter elements. J BIOL CHEM , 271 (34) 20853 - 20860. Gold open access

Liu, YZ; Dawson, SJ; Latchman, DS; (1996) Alternative splicing of the Brn-3a and Brn-3b transcription factor RNAs is regulated in neuronal cells. J MOL NEUROSCI , 7 (1) 77 - 85.

Morris, PJ; Lakin, ND; Dawson, SJ; Ryabinin, AE; Kilimann, MW; Wilson, MC; Latchman, DS; (1996) Differential regulation of genes encoding synaptic proteins by members of the Brn-3 subfamily of POU transcription factors. MOL BRAIN RES , 43 (1-2) 279 - 285.

1995

Deans, L; Dawson, SJ; Buttery, L; Polak, JM; Wallace, D; Latchman, DS; (1995) Direct evidence that the POU family transcription factor Oct-2 represses the cellular tyrosine hydroxylase gene in neuronal cells. J MOL NEUROSCI , 6 (3) 159 - 167.

GREEN, FR; LANE, A; THOMAS, AE; DAWSON, S; MILLER, G; HAMSTEN, A; HUMPHRIES, SE; (1995) GENE ENVIRONMENT INTERACTIONS AND THE RISK OF THROMBOSIS. In: Woodford, FP and Davignon, J and Sniderman, A, (eds.) ATHEROSCLEROSIS X. (pp. 805 - 807). ELSEVIER SCIENCE PUBL B V

Ye, S; Green, FR; Scarabin, PY; Nicaud, V; Bara, L; Dawson, SJ; ... Cambou, JP; + view all (1995) The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde. Thromb Haemost , 74 (3) 837 - 841.

YE, S; GREEN, FR; SCARABIN, PY; NICAUD, V; BARA, L; DAWSON, SJ; ... CAMBIEN, F; + view all (1995) THE 4G/5G GENETIC-POLYMORPHISM IN THE PROMOTER OF THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) GENE IS ASSOCIATED WITH DIFFERENCES IN PLASMA PAI-1 ACTIVITY BUT NOT WITH RISK OF MYOCARDIAL-INFARCTION IN THE ECTIM STUDY. THROMB HAEMOSTASIS , 74 (3) 837 - 841.

1994

DAWSON, SJ; YOON, SO; CHIKARAISHI, DM; LILLYCROP, KA; LATCHMAN, DS; (1994) THE OCT-2 TRANSCRIPTION FACTOR REPRESSES TYROSINE-HYDROXYLASE EXPRESSION VIA A HEPTAMER TAATGARAT-LIKE MOTIF IN THE GENE PROMOTER. NUCLEIC ACIDS RES , 22 (6) 1023 - 1028. Gold open access

LILLYCROP, KA; DAWSON, SJ; ESTRIDGE, JK; GERSTER, T; MATTHIAS, P; LATCHMAN, DS; (1994) REPRESSION OF A HERPES-SIMPLEX VIRUS IMMEDIATE-EARLY PROMOTER BY THE OCT-2 TRANSCRIPTION FACTOR IS DEPENDENT ON AN INHIBITORY REGION AT THE N-TERMINUS OF THE PROTEIN. MOL CELL BIOL , 14 (11) 7633 - 7642.

1993

DAWSON, SJ; WIMAN, B; HAMSTEN, A; GREEN, F; HUMPHRIES, S; HENNEY, AM; (1993) THE 2 ALLELE SEQUENCES OF A COMMON POLYMORPHISM IN THE PROMOTER OF THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) GENE RESPOND DIFFERENTLY TO INTERLEUKIN-1 IN HEPG2 CELLS. J BIOL CHEM , 268 (15) 10739 - 10745. Gold open access

1992

DAWSON, S; HENNEY, A; (1992) THE STATUS OF PAI-1 AS A RISK FACTOR FOR ARTERIAL AND THROMBOTIC DISEASE - A REVIEW. ATHEROSCLEROSIS , 95 (2-3) 105 - 117.

Humphries, SE; Green, FR; Temple, A; Dawson, S; Henney, A; Kelleher, CH; ... Hamsten, A; + view all (1992) Genetic factors determining thrombosis and fibrinolysis. Ann Epidemiol , 2 (4) 371 - 385.

HUMPHRIES, SE; LANE, A; DAWSON, S; GREEN, FR; (1992) THE STUDY OF GENE-ENVIRONMENT INTERACTIONS THAT INFLUENCE THROMBOSIS AND FIBRINOLYSIS - GENETIC-VARIATION AT THE LOCI FOR FACTOR-VII AND PLASMINOGEN-ACTIVATOR INHIBITOR-1. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE , 116 (12) 1322 - 1329.

THOMAS, AE; GREEN, FR; DAWSON, SJ; LANE, A; HENNEY, AM; KELLEHER, CH; ... HUMPHRIES, SE; + view all (1992) POSSIBILITIES OF DNA ANALYSIS FOR THE DETECTION OF PREDISPOSITION TO THROMBOTIC DISEASE. ANN NY ACAD SCI , 667 332 - 342.

THOMAS, AE; GREEN, FR; DAWSON, SJ; LANE, A; HENNEY, AM; KELLEHER, CH; ... HUMPHRIES, SE; + view all (1992) POSSIBILITIES OF DNA ANALYSIS FOR THE DETECTION OF PREDISPOSITION TO THROMBOTIC DISEASE. PLASMINOGEN ACTIVATION IN FIBRINOLYSIS, IN TISSUE REMODELING, AND IN DEVELOPMENT , 667 332 - 342.

1991

DAWSON, S; HAMSTEN, A; WIMAN, B; HENNEY, A; HUMPHRIES, S; (1991) GENETIC-VARIATION AT THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 LOCUS IS ASSOCIATED WITH ALTERED LEVELS OF PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY. ARTERIOSCLER THROMB , 11 (1) 183 - 190.

DAWSON, SJ; WIMAN, B; HAMSTEN, A; GREEN, F; HENNEY, AM; HUMPHRIES, S; (1991) A COMMON POLYMORPHISM IN THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) PROMOTER SHOWS ALLELE SPECIFIC DIFFERENTIAL BINDING TO HEPG2 NUCLEAR EXTRACTS AND IS ASSOCIATED WITH ALTERED PLASMA PAI-1 LEVELS. AM J HUM GENET , 49 (4) 426 - 426.

DAWSON, SJ; WIMAN, B; HAMSTEN, A; GREEN, F; HENNEY, AM; HUMPHRIES, S; (1991) ALLELE SPECIFIC DIFFERENTIAL BINDING OF HEPG2 NUCLEAR EXTRACTS TO A COMMON POLYMORPHISM IN THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) PROMOTER WHICH IS ASSOCIATED WITH ALTERED PLASMA PAI-1 LEVELS. THROMB HAEMOSTASIS , 65 (6) 806 - 806.

HENNEY, AM; GREEN, FR; DAWSON, SJ; YE, S; LANE, A; HUMPHRIES, SE; ... BARA, L; + view all (1991) PAI-1 AND FACTOR-VII GENE POLYMORPHISMS AND ASSOCIATION WITH PLASMA-LEVELS IN THE ECTIM STUDY, A MULTICENTER, CASE-CONTROL STUDY OF MYOCARDIAL-INFARCTION. THROMB HAEMOSTASIS , 65 (6) 993 - 993.

HUMPHRIES, SE; GREEN, F; DAWSON, S; HAMSTEN, A; (1991) INTERACTION BETWEEN GENOTYPE AND ENVIRONMENTAL-FACTORS IN THE DEVELOPMENT OF ATHEROSCLEROTIC-THROMBOTIC ARTERIAL DISEASES. THROMB HAEMOSTASIS , 65 (6) 816 - 816.

1990

DAWSON, S; HAMSTEN, A; WIMAN, B; HENNEY, A; HUMPHRIES, S; (1990) GENETIC-VARIATION AT THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) LOCUS. FIBRINOLYSIS , 4 51 - 53.

DAWSON, SJ; HENNEY, AM; HUMPHRIES, S; HAMSTEN, A; (1990) USE OF PCR TO GENOTYPE A POLYMORPHIC DINUCLEOTIDE REPEAT WITHIN THE PAI-1 GENE IN PATIENTS WITH A RECENT MI. J MED GENET , 27 (3) 207 - 207.

POWELL, JT; BASHIR, A; DAWSON, S; VINE, N; HENNEY, AM; HUMPHRIES, SE; GREENHALGH, RM; (1990) GENETIC-VARIATION ON CHROMOSOME-16 IS ASSOCIATED WITH ABDOMINAL AORTIC-ANEURYSM. CLIN SCI , 78 (1) 13 - 16.

This list was generated on Sun Sep 14 04:13:51 2014 BST.

Page last modified on 19 jan 12 10:07